We are live on ! Find out more
KCM

Kennedy Capital Management Portfolio holdings

AUM $4.72B
1-Year Est. Return 36.69%
This Fund
S&P 500
This Quarter Est. Return
-1.02%
1 Year Est. Return
+36.69%
3 Year Est. Return
+98.85%
5 Year Est. Return
+128.89%
10 Year Est. Return
+548.51%
AUM
$4.68B
AUM Growth
-$181M
Cap. Flow
-$34.8M
Cap. Flow %
-0.74%
Top 10 Hldgs %
8.18%
Holding
777
New
55
Increased
288
Reduced
331
Closed
83

Sector Composition

Rank Sector Weight
1 Industrials 19.39%
2 Financials 18.62%
3 Healthcare 16.37%
4 Technology 13.36%
5 Consumer Discretionary 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTH icon
651
Meritage Homes
MTH
$4.67B
$249K 0.01%
3,082
GERN icon
652
Geron
GERN
$949M
$249K 0.01%
58,700
-1,066,580
-95% -$4.16M
ITCI
653
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$245K 0.01%
3,574
-15,747
-82% -$1.09M
CYTK icon
654
Cytokinetics
CYTK
$10.5B
$244K 0.01%
4,496
+1,304
+41% +$78.7K
FTDR icon
655
Frontdoor
FTDR
$5.88B
$235K 0.01%
+6,951
New +$234K
ABSI icon
656
Absci
ABSI
$1.53B
$234K 0.01%
75,981
+12,880
+20% +$59.7K
PHM icon
657
Pultegroup
PHM
$24.6B
$231K ﹤0.01%
2,099
NAMS icon
658
NewAmsterdam Pharma
NAMS
$3.33B
$228K ﹤0.01%
+11,853
New +$238K
PRPO icon
659
Precipio
PRPO
$42.5M
$217K ﹤0.01%
41,894
+934
+2% +$5.54K
EBMT icon
660
Eagle Bancorp Montana
EBMT
$185M
$215K ﹤0.01%
16,239
SLND icon
661
Southland Holdings
SLND
$34.2M
$200K ﹤0.01%
43,668
-28,113
-39% -$139K
EPIX
662
DELISTED
ESSA Pharma
EPIX
$181K ﹤0.01%
+34,465
New +$219K
XRN
663
Chiron Real Estate Inc
XRN
$473M
$170K ﹤0.01%
3,746
+126
+3% +$5.48K
SONO icon
664
Sonos
SONO
$1.86B
$168K ﹤0.01%
+11,379
New +$189K
FTK icon
665
Flotek Industries
FTK
$1.36B
$158K ﹤0.01%
+32,228
New +$127K
SPWH icon
666
Sportsman's Warehouse
SPWH
$46.8M
$150K ﹤0.01%
62,160
+2,101
+3% +$6.67K
KRON
667
DELISTED
Kronos Bio
KRON
$146K ﹤0.01%
117,637
+2,576
+2% +$2.62K
CMPS
668
Compass Pathways
CMPS
$1.77B
$142K ﹤0.01%
23,565
+6,825
+41% +$53.7K
XGN icon
669
Exagen
XGN
$160M
$139K ﹤0.01%
+76,513
New +$130K
PRLD icon
670
Prelude Therapeutics
PRLD
$387M
$134K ﹤0.01%
35,283
+10,248
+41% +$41.7K
CMRX
671
DELISTED
Chimerix, Inc.
CMRX
$118K ﹤0.01%
+135,220
New +$128K
CVGI icon
672
Commercial Vehicle Group
CVGI
$139M
$116K ﹤0.01%
23,745
-13,983
-37% -$79.2K
MGTX icon
673
MeiraGTx Holdings
MGTX
$1.2B
$97.5K ﹤0.01%
23,160
+6,703
+41% +$33.8K
DOUG icon
674
Douglas Elliman
DOUG
$167M
$84.8K ﹤0.01%
73,126
-8,326
-10% -$10.5K
AFMD
675
DELISTED
Affimed
AFMD
-10,106
Closed -$53.6K

Similar funds

Kennedy Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Kennedy Capital Management held 777 positions worth $4.68B, down 3.7% from $4.86B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

Kennedy Capital Management's Q2 2024 filing shows 55 new, 288 increased, 331 reduced and 83 closed positions. Its largest new stake was Selective Insurance: 141,753 shares worth $13.3M. The largest sale was Pioneer Natural Resource Co., an estimated $14.7M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

  • Kennedy Capital Management's largest Q2 2024 buy was Selective Insurance: 141,753 shares worth $13.3M.
  • Kennedy Capital Management added most to Hexcel in Q2 2024, an estimated $19.5M increase.
  • Kennedy Capital Management's biggest Q2 2024 reduction was Blue Bird Corp, cutting an estimated $13.3M.
  • Kennedy Capital Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $14.7M.
  • Kennedy Capital Management's ten largest holdings make up 8.2% of its $4.68B portfolio in Q2 2024.
  • Kennedy Capital Management opened 55 new positions and closed 83 in Q2 2024.
  • Kennedy Capital Management's portfolio value fell 3.7% quarter-over-quarter to $4.68B.

Based on Kennedy Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.